Logo image
An open-label efficacy trial of escitalopram for night eating syndrome
Journal article   Peer reviewed

An open-label efficacy trial of escitalopram for night eating syndrome

Kelly C. Allison, Stacia K. Studt, Robert I. Berkowitz, Louise A. Hesson, Reneé H. Moore, Jacob G. Dubroff, Andrew Newberg and Albert J. Stunkard
Eating behaviors : an international journal, v 14(2), pp 199-203
01 Apr 2013
PMID: 23557820

Abstract

Binge eating disorder Eating disorders Insomnia Night eating syndrome SSRIs
Night eating syndrome (NES) has become increasingly recognized as a disorder in need of effective treatments. Selective serotonin reuptake inhibitors have shown efficacy in previous trials, so we sought to expand our understanding of the efficacy of escitalopram in the current trial. Thirty-one adults with NES participated in a 12-week open-label trial of escitalopram. Outcome measures included the Night Eating Symptom Scale (NESS), percent of daily intake after the evening meal (% intake) and number of nocturnal ingestions/week (NI), weight, total awakenings/week, mood, and quality of life. Mixed-effects models were used to assess change over time. Significant reductions were observed from week 0 to week 12 for the NESS (30.2 to 15.2), % intake (46% to 17%), NI (5.8 to 1.2), weight (90.2 to 88.6kg), awakenings (8.1 to 2.7), and BDI-II (12.1 to 7.7). Outcomes did not differ significantly by gender, age, race, or psychiatric co-morbidity status. Eighteen of 31 completed 12weeks of treatment. This open-label trial of escitalopram showed significant reductions in symptoms associated with NES. Randomized controlled trials are warranted to test these findings. Trial Registration: clinicaltrials.gov identifier: NCT01401595. •Open label escitalopram reduced all core symptoms of night eating syndrome.•Co-morbid psychopathology was common but did not affect outcomes.•Additional larger, randomized trials of escitalopram seem warranted.

Metrics

5 Record Views
27 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#5 Gender Equality
#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Psychiatry
Psychology, Clinical
Logo image